Phaseline

Targets › CTXB

CTXB: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 1; Vaccines; next expected readout Nov 2026.

Open in Phaseline: the race on CTXB, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Centre for Infectious Disease Research in ZambiaPanChol
Live attenuated oral cholera vaccine with El Tor background and genetic modifications to r
CTXBPhase 1Cholera Vaccination ReactionNov 2026

Conditions

Cholera Vaccination Reaction (1)

Modalities

protein or peptide (1)

Companies

Centre for Infectious Disease Research in Zambia (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.